Extended Data Fig. 6: Risk of post-acute sequelae in people with breakthrough SARS-CoV-2 infection compared to those with SARS-CoV-2 infection without prior vaccination. | Nature Medicine

Extended Data Fig. 6: Risk of post-acute sequelae in people with breakthrough SARS-CoV-2 infection compared to those with SARS-CoV-2 infection without prior vaccination.

From: Long COVID after breakthrough SARS-CoV-2 infection

Extended Data Fig. 6: Risk of post-acute sequelae in people with breakthrough SARS-CoV-2 infection compared to those with SARS-CoV-2 infection without prior vaccination.

Incident outcomes were assessed from 30 days after the positive SARS-CoV-2 test to end of follow-up. Results are in comparison of breakthrough SARS-CoV-2 infection (n=33,940) to those with SARS-CoV-2 infection without prior vaccination (n=113,474). Adjusted hazard ratios (dots) and 95% confidence intervals (error bars) are presented. Myocarditis (hazard ratio: 0.05; 95% confidence intervals: 0.01, 0.38) was not plotted to remove excess x-axis scaling.

Back to article page